AMANDA ALEXANDER: Open Payments
NPI 1255020327 · AUGUSTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,410 in 72 payments from 15 companies in 2025. Trend: 2023 $473 · 2024 $2,171 · 2025 $1,410
Food & beverage: $1,297Education: $113
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $545 |
| Janssen Biotech, Inc. | 5 | $186 |
| UCB, Inc. | 11 | $170 |
| GENZYME CORPORATION | 7 | $142 |
| PFIZER INC. | 3 | $56 |
| Amgen Inc. | 2 | $52 |
| Lilly USA, LLC | 2 | $50 |
| Incyte Corporation | 2 | $50 |
| Organon LLC | 5 | $46 |
| Regeneron Healthcare Solutions, Inc. | 1 | $32 |
Products named: SKYRIZI, TREMFYA, DUPIXENT, Bimzelx, RINVOQ, CIBINQO, OTEZLA, EBGLYSS.
Industry payments across GA — which companies pay providers there.
